CVE-2021-33017

Executive Summary

CVE-2021-33017 is an authentication bypass vulnerability affecting the Philips IntelliBridge EC 40 and EC 80 Hub firmware versions C.00.04 and prior. The vulnerability stems from an alternate path or channel within the product that bypasses the authentication requirement enforced on the standard access path, allowing unauthenticated access to the device. This vulnerability is particularly critical in healthcare environments because the IntelliBridge Hub serves as a central integration point for patient monitoring data, and unauthorized access could expose sensitive patient information or allow an attacker to manipulate data flows between medical devices and hospital information systems. With a CVSS score of 8.1 and no known patch currently available, this vulnerability represents a significant and ongoing risk to healthcare organizations that have not yet mitigated the exposure through network-level controls.

Technical Analysis

The NVD description indicates that the IntelliBridge EC 40 and EC 60 Hub (C.00.04 and prior) requires authentication on its standard access path, but the product contains an alternate path or channel that does not require authentication. Note the discrepancy in the description: the CNA title references both "EC 40 and EC 80 Hub" while the NVD description mentions "EC 40 and 60 Hub" — both model identifiers should be considered in scope for this advisory.

The vulnerability class here is CWE-288: Authentication Bypass Using an Alternate Path. This class of vulnerability occurs when a system implements authentication controls on one interface (the "standard access path") but fails to enforce the same authentication requirements on parallel or secondary interfaces. Typical manifestations in embedded medical devices include:

• Alternative management interfaces: A device may expose a secondary administration interface (such as a debug console, maintenance port, or service API) that was intended for factory configuration or field service but remains accessible in production.
• Unauthenticated data channels: A data exchange endpoint (e.g., an API used for device integration) may not enforce authentication because it was assumed to be network-isolated from untrusted traffic.
• Bypass via protocol switching: The device may process the same command via multiple protocols where one is protected and another is not.

Insufficient technical detail is available in the NVD entry to determine the exact nature of the alternate path — whether it is a network service, a physical serial port, or a secondary application-layer protocol. The CVSS vector breakdown (score 8.1, with high impacts to confidentiality, integrity, and availability) suggests that the bypass provides significant control over the device's operations.

The attack surface is the network-exposed interfaces of the IntelliBridge Hub. The hub acts as a central aggregation point for patient monitoring data and typically connects to hospital networks to relay physiological data (heart rate, blood pressure, oxygen saturation, etc.) to electronic health records and central monitoring stations. Any unauthenticated alternate path to this device presents a severe risk to both patient data confidentiality and the integrity of the clinical data stream.

Exploitation Scenarios

Note: No public PoC is available; the attack chain is inferred from the vulnerability class (CWE-288) and the NVD description. Specific technical details beyond those provided in the CVE data are not available.

Step 1: Reconnaissance / Target Identification

An attacker operating from within the hospital network (or from an external position if the hub is exposed to the internet) would first identify IntelliBridge Hubs using network scanning. Network enumeration techniques could identify the devices via:

• Service banner grabbing on management ports
• SNMP community string queries
• Network protocol analysis targeting medical device communication standards

Given the "alternate path or channel" nature of this vulnerability, the attacker would likely probe all accessible ports and services on the device to identify any endpoint that responds without demanding authentication credentials.

Step 2: Triggering the Vulnerability

Once an alternate service or endpoint is identified, the attacker would send requests directly to that path without authenticating. Because the alternate channel does not require authentication, the device would process the request as if it came from a legitimate, authenticated client. The exact trigger mechanism depends on the specific implementation of the alternate path, which is not detailed in the public advisory.

Step 3: Payload / Execution Method

At the vulnerability-class level, the attacker would leverage the unauthenticated alternate channel to issue commands or access data that should be restricted to authenticated users. Depending on what the alternate path exposes, this could manifest as:

• Sending management commands to reconfigure the device
• Accessing patient monitoring data streams without authorization
• Modifying device configuration to disrupt data flow

Insufficient technical detail is available to specify the exact command set or protocol used on the alternate channel.

Step 4: Post-Exploitation Impact

Post-exploitation outcomes depend on the attacker's objectives. In a healthcare context, the potential impacts include:

• Data theft: Exfiltration of patient physiological data, potentially violating HIPAA and other regulatory frameworks
• Data integrity compromise: Manipulation of patient monitoring data, which could lead to incorrect clinical decisions
• Availability disruption: Denial of service against the hub, interrupting the flow of patient data to monitoring stations
• Lateral movement: Using the hub as a foothold to pivot to other medical devices and hospital network assets

Impact Assessment

The CVSS score of 8.1 (High) reflects significant impacts across all three security pillars:

• Confidentiality Impact: High — An unauthenticated attacker can potentially access patient monitoring data traversing the hub. In healthcare, this data is PHI (Protected Health Information) and subject to strict regulatory oversight.
• Integrity Impact: High — Unauthorized access to the alternate path could allow an attacker to modify device configuration or tamper with data being relayed, potentially causing incorrect patient data to be displayed to clinicians.
• Availability Impact: High — Compromise of the hub could result in denial-of-service conditions that disrupt critical patient monitoring.

Affected Systems

• Philips IntelliBridge EC 40 Hub — firmware C.00.04 and prior
• Philips IntelliBridge EC 80 Hub — firmware C.00.04 and prior (per CNA title)
• Philips IntelliBridge EC 60 Hub — firmware C.00.04 and prior (per NVD description)

Blast Radius

The IntelliBridge Hub is typically deployed in intensive care units (ICUs), operating rooms, and other critical care settings where continuous patient monitoring is essential. A compromise could affect multiple patient beds simultaneously, as the hub aggregates data from multiple monitoring devices.

Propagation Risk

While this is a network-based vulnerability without inherent self-propagation capability, the access gained could facilitate lateral movement to other devices on the hospital network, particularly if the hub is on a segment with limited isolation from other clinical systems.

Detection Guidance

Sigma Rule

title: Philips IntelliBridge Hub Unauthenticated Access Attempt
id: 4f2a1c8e-3b7d-4e9a-9f1c-2d5e8a0b6f3d
status: experimental
description: Detects network connections to Philips IntelliBridge Hub alternate access paths that may indicate CVE-2021-33017 exploitation attempts
author: valtersit.com Threat Intel
logsource:
  category: network_connection
  product: windows
detection:
  selection:
    DestinationPort:
      - '5000'
      - '8080'
      - '8443'
    DestinationHostname:
      - '*intellibridge*'
      - '*ec40*'
      - '*ec80*'
      - '*ec60*'
  condition: selection
fields:
  - DestinationIp
  - SourceIp
  - DestinationPort
  - User
falsepositives:
  - Legitimate maintenance or configuration activity by Philips service personnel
  - Automated discovery tools performing network scans
level: medium

YARA Rule

rule Philips_IntelliBridge_Alt_Path
{
    meta:
        author = "valtersit.com Threat Intel"
        description = "Detect network traffic patterns associated with unauthenticated access to Philips IntelliBridge Hub alternate paths"
        reference = "CVE-2021-33017"
        date = "2024-01-15"
        score = 60
    strings:
        $s1 = "IntelliBridge" ascii nocase
        $s2 = "EC40" ascii nocase
        $s3 = "EC60" ascii nocase
        $s4 = "EC80" ascii nocase
        $s5 = "hub" ascii nocase
        $s6 = "config" ascii nocase
        $s7 = "monitor" ascii nocase
        $s8 = "patient" ascii nocase
        $s9 = "status" ascii nocase
        $s10 = "reboot" ascii nocase
    condition:
        uint16(0) == 0x0a0a or uint16(0) == 0x0d0a and 3 of them
}

Suricata IDS Rule

alert tcp any any -> $HOME_NET [5000,8080,8443,9100] (msg:"CVE-2021-33017 - Philips IntelliBridge Hub Unauthenticated Access Attempt"; flow:to_server,established; content:"IntelliBridge"; nocase; content:!"HTTP"; metadata:ruleset valtersit-cve-2021-33017; reference:cve,2021-33017; classtype:attempted-admin; sid:100001; rev:1;)

Elastic Detection

network where event.category == "connection" and network.direction == "inbound" and
  destination.port in (5000, 8080, 8443, 9100) and
  destination.hostname like "*intellibridge*"

Splunk SPL Query

index=netflow OR index=network sourcetype=cisco:asa OR sourcetype=pan:traffic
| where match(dest_host, "(?i)intellibridge") OR match(dest_host, "(?i)ec40|ec60|ec80")
| where dest_port IN (5000, 8080, 8443, 9100)
| stats count by src_ip, dest_ip, dest_port, _time
| sort - _time
| table _time, src_ip, dest_ip, dest_port, count

Wazuh OSSEC Rule

<group name="medical,">
  <rule id="100101" level="10">
    <decoded_as>json</decoded_as>
    <field name="event">connection</field>
    <match>IntelliBridge</match>
    <description>Unauthenticated connection attempt to Philips IntelliBridge Hub (CVE-2021-33017)</description>
    <mitre>
      <id>T1190</id>
    </mitre>
  </rule>
</group>

Mitigation & Patch Guidance

Patch Confidence: 0/4 — UNPATCHED. No patch evidence from any tracked source. No vendor fix has been identified at the time of this report.

1) Immediate Mitigations

Since no vendor patch is available, immediate mitigation must focus on network-level controls:

• Network segmentation: Isolate IntelliBridge Hubs on a dedicated VLAN with strict access control lists. Restrict inbound connections to only the specific systems (central monitoring stations, EHR integration servers) that require legitimate access to the hub.
• Firewall rules: Block all unnecessary inbound traffic to the IntelliBridge Hub. If the alternate path is on a known port, block that port at the network perimeter and on internal segmentation devices.
• Access control: Implement IP-based allowlisting to restrict which source addresses can initiate connections to the hub.
• Monitoring: Enable logging on all network devices that interface with the IntelliBridge Hub and alert on any new or unexpected connections.
• Inventory assessment: Identify all IntelliBridge EC 40, EC 60, and EC 80 Hubs in the environment and verify they are running C.00.04 or prior versions, making them vulnerable. Confirm firmware versions for all units.

2) Patch / Upgrade Steps

• Contact Philips for the latest firmware and security advisories.
• As of this report, no patch is available. If a patch is released, prioritize deployment to vulnerable hubs.
• Ensure a change management process is in place to handle firmware updates, as these devices are often safety-critical and should not be updated without coordination with clinical engineering teams.

3) Long-Term Hardening

• Procurement standards: Require that future medical device purchases include contractual commitments to security patch support and vulnerability disclosure timelines.
• Security architecture: Design medical device networks using the principles of least privilege and zero trust, where every access request — including to medical devices — is authenticated and authorized.
• Continuous monitoring: Deploy medical device security monitoring tools (e.g., specialized OT/medical device security platforms) that can detect anomalous behavior on clinical networks.
• Incident response readiness: Develop and test an incident response playbook specific to medical device compromise, including procedures for isolating affected devices without disrupting patient care.
• Compliance review: Ensure that mitigation strategies align with regulatory requirements (HIPAA, FDA guidance on cybersecurity in medical devices) and document all risk acceptance decisions.

References

1. NVD Entry — CVE-2021-33017: https://nvd.nist.gov/vuln/detail/CVE-2021-33017
2. Philips Product Security Page: https://www.philips.com/a-w/security/security-advisories.html
3. CWE-288: Authentication Bypass Using an Alternate Path — https://cwe.mitre.org/data/definitions/288.html
4. CISA Known Exploited Vulnerabilities Catalog: https://www.cisa.gov/known-exploited-vulnerabilities-catalog (CVE-2021-33017 NOT listed — no known exploitation in the wild)
5. AT&T&CK T1190 — Exploit Public-Facing Application: https://attack.mitre.org/techniques/T1190/

Threat Actor Intelligence: No known threat actor campaigns or exploit-in-the-wild evidence associated with CVE-2021-33017. The CISA KEV catalog does not list this CVE, and the EPSS score of 0.00453 (37.3% percentile) suggests a relatively low current exploitation probability. However, the healthcare sector remains a high-value target, and the lack of an available patch elevates the risk profile for organizations deploying these devices.